<DOC>
	<DOCNO>NCT01546922</DOCNO>
	<brief_summary>The aim study investigate whether physiologically low hydrocortisone ( HC ) dose good cognition compare physiologically high HC dose . In addition , quality life , metabolic profile somatosensation describe relation HC dose .</brief_summary>
	<brief_title>Hydrocortisone Replacement Patients With Secondary Adrenal Insufficiency ( SUPREME CORT )</brief_title>
	<detailed_description>- Rationale : A wide variety hydrocortisone ( HC ) substitution dose-regimens consider physiological patient adrenal insufficiency . However , likely cognition negatively influence high cortisol exposure brain . No study perform assess effect treatment regimens low physiological HC substitution dose cognition comparison high physiological HC substitution dose . These treatment regimen take body weight multiple dose account . In addition , substitution dos monitor clinical evaluation biochemical analysis adverse effect associate over- under-replacement . - Intervention : Patients secondary adrenal insufficiency randomize two group receive either low dose HC ( 0.2-0.3 mg/kg body weight ) 10 week follow 10 week high dose HC ( 0.4-0.6 mg/kg body weight ) vice versa . At baseline treatment period , patient test .</detailed_description>
	<mesh_term>Adrenal Insufficiency</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Patients secondary adrenal insufficiency . Age ≥ 18 75 year ≥ One year tumor treatment surgery and/or radiotherapy On stable concomitant medication least six month prior entry study Body weight 50100 kg Inability legal consent Documented cognitive impairment Drug abuse/dependence History / current psychiatric disorder Use antiepileptic ( e.g . carbamezapine ) Cushing Disease Type 1 diabetes Type 2 diabetes medication know induce hypoglycemia ( f.e . Sulfonylurea derivatives Current treatment second malignancy Have significant medical condition ( e.g . hepatic , respiratory , cardiovascular ) , opinion investigator , may interfere interpretation result safety efficacy evaluation . A history frequent hypocortisolism Hospitalization study Work shift</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Hydrocortisone</keyword>
	<keyword>Cognition</keyword>
	<keyword>Adrenal insufficiency</keyword>
	<keyword>Quality Life</keyword>
	<keyword>Common Somatic Complaints</keyword>
	<keyword>Cardiovascular/Metabolic Profile</keyword>
	<keyword>Somatosensation</keyword>
</DOC>